# A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy Volunteers

> **NCT01897844** · PHASE1 · COMPLETED · sponsor: **Italfarmaco** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ITF2984 (100, 2000, 3000 mcg bid)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01897844
- **Lead sponsor:** Italfarmaco
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01897844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01897844, "A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01897844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*